Efficacy of CT-996, an Oral Small Molecule GLP-1 Receptor Agonist, in Human GLP-1 Receptor Knockin Mice and Obese Cynomolgus Monkeys

被引：0
|
作者：
Luo, Jian
Rodriguez, Ruben
Hergarden, Anne
Tracy, Ted
Lam, Davina
Garai, Sumanta
Marshall, Dan
Hansen, Stig K.
Chakravarthy, Manu
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-771-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
771-P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Clinical Pharmacology of Albiglutide, a GLP-1 Receptor Agonist
    Young, Malcolm A.
    Wald, Jeffrey A.
    Matthews, Jessica E.
    Scott, Rhona
    Hodge, Rebecca J.
    Zhi, Hui
    Reinhardt, Rickey R.
    POSTGRADUATE MEDICINE, 2014, 126 (07) : 84 - 97
  • [22] Distinct activation of GLP-1 receptor by exendin-4 and GLP-1
    Montrose-Rafizadeh, C
    Yang, H
    Pritchette, LA
    Eng, J
    DIABETES, 1998, 47 : A192 - A192
  • [23] Novel Approach for Development of Oral GLP-1 Receptor Agonist with Superior Bioavailability and Antidiabetic Efficacy
    Park, Eun Ji
    Jeon, Ok-Cheol
    Park, Jong-Sung
    Choi, Jiyoung
    Shin, Jaehee
    Lim, Sungmook
    Park, Soobong
    Lee, Seulki
    DIABETES, 2022, 71
  • [24] Down regulation of the GLP-1 receptor caused by GLP-1 is associated to increased receptor internalization.
    Brock, B
    Gregersen, S
    Hermansen, K
    DIABETOLOGIA, 1999, 42 : A199 - A199
  • [25] Efficacy and Cardiovascular Safety of GLP-1 Receptor Analogues
    Iqbal, Anoop Mohamed
    Imamudeen, Nasvin
    Basheer, Amjad
    Menon, Sukrita
    Mohan, Gisha
    Sani, Tesil Nedumkallel
    Haroon, Nisha Nigil
    CURRENT DRUG SAFETY, 2021, 16 (02) : 197 - 206
  • [26] Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1
    Hager, Marlies V.
    Clydesdale, Lachlan
    Gellman, Samuel H.
    Sexton, Patrick M.
    Wootten, Denise
    BIOCHEMICAL PHARMACOLOGY, 2017, 136 : 99 - 108
  • [27] GLP-1 and dual GIP/GLP-1 receptor agonists increase risk of aspiration
    Reactions Weekly, 2025, 2044 (1) : 3 - 3
  • [28] GLP-1 receptor agonist on cardiovascular complications of diabetes mellitus
    Liu, Fengjun
    Kong, Yanhua
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 19 (03) : 2259 - 2265
  • [29] GLP-1 RECEPTOR AGONIST TREATMENT IN SCHIZOPHRENIA PATIENTS WITH OBESITY
    Ishoy, Pelle L.
    Knop, Filip K.
    Broberg, Brian V.
    Bak, Nikolaj
    Andersen, Ulrik B.
    Jorgensen, Niklas R.
    Fagerlund, Birgitte
    Holst, Jens J.
    Glenthoj, Birte Y.
    Ebdrup, Bjorn
    SCHIZOPHRENIA BULLETIN, 2017, 43 : S167 - S167
  • [30] Activation of the GLP-1 receptor by a non-peptidic agonist
    Peishen Zhao
    Yi-Lynn Liang
    Matthew J. Belousoff
    Giuseppe Deganutti
    Madeleine M. Fletcher
    Francis S. Willard
    Michael G. Bell
    Michael E. Christe
    Kyle W. Sloop
    Asuka Inoue
    Tin T. Truong
    Lachlan Clydesdale
    Sebastian G. B. Furness
    Arthur Christopoulos
    Ming-Wei Wang
    Laurence J. Miller
    Christopher A. Reynolds
    Radostin Danev
    Patrick M. Sexton
    Denise Wootten
    Nature, 2020, 577 : 432 - 436
12345